Dow Up 0.08% Nasdaq Down 0.30%

Novogen Limited (NVGN)

-NCM
2.97 Up 0.03(1.02%) Sep 19, 3:34PM EDT
Prev Close:2.94
Open:2.94
Bid:2.98 x 200
Ask:3.05 x 300
1y Target Est:N/A
Beta:-0.18
Next Earnings Date:N/A
Day's Range:2.87 - 3.07
52wk Range:2.72 - 6.84
Volume:3,277
Avg Vol (3m):17,489
Market Cap:20.02M
P/E (ttm):N/A
EPS (ttm):-0.78
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NVGN

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):50.91
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (0-00-31) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novogen Limited is engaged in the pharmaceutical research and development business in Australia. The company has primarily two drug technology platforms, which include super-benzopyrans (SBPs) and anti-tropomyosins (ATMs). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback